Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

GPDT Photodynamic Therapy: Oxford Researchers Shine Light on New Cancer Treatment

by
December 24, 2024
in Economy, Investing
0
GPDT Photodynamic Therapy: Oxford Researchers Shine Light on New Cancer Treatment
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Last Updated on:

Oxford researchers from Oxperial BioHealth have revealed Green Products Photodynamic Therapy (GPDT), a groundbreaking innovation in cancer care. The therapy was unveiled at the 2024 Pharmaceutical Science Conference in Barcelona and the 20th Guangzhou International Symposium on Molecular Medicine, capturing significant global interest. Branded as “Sunshine Against Cancer,” GPDT represents a transformative leap in cancer treatment.

The team, led by Dr. Daniel T. H. Chen, Dr. Ta-Chun Liu, Pharmacist Shin-Yi Huang, and Dr. Yao-Kuan Chen, showcased how GPDT—a completely plant-based therapy—induces apoptosis (programmed cell death) in cancer cells, with the process amplified by sunlight. By utilising the therapeutic potential of plant chlorophyll and other natural compounds, GPDT provides a sustainable and minimally invasive alternative to conventional treatments.

GPDT is already patented in the UK and Taiwan, with international protections in progress. This innovative therapy disrupts tumour growth and differentiation, making it a groundbreaking development in oncology. By integrating sunlight with botanical compounds, GPDT offers an eco-friendly and forward-thinking solution to one of the world’s most pressing health concerns.

The international medical community has responded enthusiastically to this breakthrough, positioning GPDT as a potential turning point in the global fight against cancer. Could sunlight and nature hold the key to revolutionary cancer treatments? This innovation brings new hope.

Cancer continues to be the leading cause of death worldwide, yet GPDT offers promising possibilities. Speaking at the 2024 Barcelona Global Pharmacology Symposium, Dr. Daniel T. H. Chen detailed GPDT’s capabilities in targeting cancer cells. By combining sunlight exposure with natural plant compounds, this therapy operates at the cellular level to inhibit cancer cell growth.

The process harnesses the 400nm-700nm wavelength of sunlight to activate botanical components, generating reactive oxygen species such as single-state oxygen molecules. These molecules have shown significant anticancer properties in laboratory settings. GPDT presents a non-invasive and complementary option for those seeking alternative approaches to treatments known for their harsh side effects.

“GPDT is the world’s first natural photodynamic solution, combining sunlight and botanicals to offer a natural option for maintaining cellular balance and supporting overall health. By integrating outdoor sunlight exposure and plant-based dietary elements, individuals can pursue a more natural, holistic path to wellness,” explained Dr. Daniel Chen.

Looking ahead, Oxperial BioHealth has announced plans to launch PropoLight, the first GPDT product, in early 2025. PropoLight, a premium health supplement, is designed to promote cellular health and support overall wellness, particularly for individuals aiming to maintain long-term well-being.

Research partner Shin-Yi Huang revealed that PropoLight will undergo further certifications and clinical trials in both the UK and US to prepare for its pharmaceutical-grade iteration. This rigorous process will pave the way for its introduction to the global market.

PropoLight’s launch signifies an important step in merging natural health products with lifestyle-oriented wellness solutions. Oxperial BioHealth intends to broaden its offerings with advanced pharmaceutical-grade options, continuing to drive innovation in holistic health on a global scale.

ShareTweetPin

Related Posts

Editor’s Picks: Gold Faces Bumpy Week on Trade Tensions, Platinum Stages Breakout
Investing

Editor’s Picks: Gold Faces Bumpy Week on Trade Tensions, Platinum Stages Breakout

June 1, 2025
Top 5 Canadian Mining Stocks This Week: Adyton Sparkles with 97 Percent Gain
Investing

Top 5 Canadian Mining Stocks This Week: Adyton Sparkles with 97 Percent Gain

May 31, 2025
NVIDIA Rallies After Strong Q1, AI Demand Outshines China Export Hit
Investing

NVIDIA Rallies After Strong Q1, AI Demand Outshines China Export Hit

May 31, 2025
CDX May Investor Presentation
Investing

CDX May Investor Presentation

May 30, 2025
Trump’s Nuclear Revival Plan Boosts Uranium Prices, Sends US Miners Soaring
Investing

Trump’s Nuclear Revival Plan Boosts Uranium Prices, Sends US Miners Soaring

May 30, 2025
Fintech Firm Velocity Raises US$10 Million for Enterprise Stablecoin Infrastructure
Investing

Fintech Firm Velocity Raises US$10 Million for Enterprise Stablecoin Infrastructure

May 29, 2025
Next Post
Homebase lives on as CDS revives DIY chain within newly branded the range stores

Homebase lives on as CDS revives DIY chain within newly branded the range stores

Recommended

Top Considerations For Choosing a Container Handling Company

Top Considerations For Choosing a Container Handling Company

December 4, 2024
Nearly half of UK small businesses unaware of new simpler recycling reforms, survey reveals

Nearly half of UK small businesses unaware of new simpler recycling reforms, survey reveals

August 9, 2024
5 Things to Consider When Choosing a Crypto Wallet

5 Things to Consider When Choosing a Crypto Wallet

November 20, 2024
Synology bets on PHL businesses’ shift to secure data management

Synology bets on PHL businesses’ shift to secure data management

October 9, 2024
New sites and spaces for Philippines’ lifestyle malls

New sites and spaces for Philippines’ lifestyle malls

September 19, 2024
PHL joins UN vote vs Israel’s occupation of Palestine

PHL joins UN vote vs Israel’s occupation of Palestine

September 22, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Terms & Conditions
    • Thank you

    Copyright © 2024 investdailypro.com | All Rights Reserved